Образование и специализация

• 1988–1992 Istanbul University Cerrahpaşa Faculty of Medicine — медицинское образование
• 1992–1997 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Internal Medicine — специализация по внутренним болезням
• 2000–2003 Trakya University Faculty of Medicine, Division of Hematology — специализация по гематологии

Профессиональный опыт

• 2003–2007 Trakya University Faculty of Medicine, Department of Internal Medicine — преподаватель
• 2007–2010 Trakya University Faculty of Medicine, Department of Internal Medicine — доцент
• 2010–2013 Namık Kemal University Faculty of Medicine, Department of Internal Medicine — доцент
• 2012 Namık Kemal University Faculty of Medicine, Department of Internal Medicine — профессор

Международный опыт

• 2007 University of Chicago Stem Cell Transplant Center — шестимесячный опыт в области трансплантации стволовых клеток (костного мозга)

Профессиональное членство

• 2019–2021 Президент Hematology Education and Research Association
• American Society of Hematology
• Turkish Apheresis Society
• Turkish Society of Hematology

Награды

• Первая премия, отраслевая награда 32-го Национального конгресса по гематологии, Turkish Society of Hematology, 2006

Избранные научные публикации

• Yeşilaltay Alpay et al. (2024). Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma. Pathogens, 13. DOI: 10.3390/pathogens13010072.
• Baysal Mehmet et al. (2023). Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores. Turkish Journal of Hematology, 40. DOI: 10.4274/tjh.galenos.2023.2023.0295.
• Broome Catherine M. et al. (2023). Efficacy and Safety of Efgartigimod in Adults with Primary Immune Thrombocytopenia (ADVANCE IV). The Lancet. DOI: 10.1016/S0140-6736(23)01460-5.
• Özatlı Düzgün et al. (2023). International Forum: The Turkish Perspective on Apheresis Activity. Transfusion and Apheresis Science, 62(2). DOI: 10.1016/j.transci.2023.103662.
• Altındağ Avcı Burcu et al. (2023). Patients with Severe Coronavirus Disease 2019 Have High Frequency of Factor V Leiden and Prothrombin Gene Mutations. Blood Coagulation & Fibrinolysis, 34(1), 14–19. DOI: 10.1097/MBC.0000000000001167.

Редакторский опыт

• Редактор специального выпуска по лимфомам (TR Dizin), Ortadoğu Reklam Yayımcılık